Conditioning regimen with a 75% dose of standard busulfan/cyclophosphamide plus fludarabine before cord blood transplantation in older patients with AML and MDS-Reference-Cited by-同舟云学术

Conditioning regimen with a 75% dose of standard busulfan/cyclophosphamide plus fludarabine before cord blood transplantation in older patients with AML and MDS

Published:2019-06-13 Issue:3 Volume:110 Page:347-354
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Ohta Takanori,Sugio Yasuhiro,Imanaga Hiroshi,Oku Seidou,Ohno Yuju

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-019-02688-w.pdf

Reference29 articles.

1. Yanada M, Naoe T. Acute myeloid leukemia in older adults. Int J Hematol. 2012;96:186–93.

2. Estey E, Döhner H. Acute myeloid leukemia. Lancet. 2006;368:1894–907.

3. Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE, et al. Age and acute myeloid leukemia. Blood. 2006;107:3481–5.

4. Konuma T, Tsukada N, Kanda J, Uchida N, Ohno Y, Miyakoshi S, et al. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older. Am J Hematol. 2016;91:E284–92.

5. Tong J, Sun Z, Liu H, Geng L, Ding K, Wang X, et al. A myeloablative conditioning regimen with fludarabine demonstrates good results in UCBT for 30 pediatric patients with hematologic malignancies, especially acute lymphoblastic leukemia. Neoplasma. 2014;61:593–600.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan;Annals of Hematology;2021-02-23

2. Conditioning regimen of single-unit cord blood transplantation for hematological malignancy;Japanese Journal of Transplantation and Cellular Therapy;2021

3. Is outcome of older people with acute myeloid leukemia improving with new therapeutic approaches and stem cell transplantation?;Expert Review of Hematology;2020-01-22